These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit. Boggs JG, Preis K. Epilepsia; 2005 Jun; 46(6):949-51. PubMed ID: 15946337 [Abstract] [Full Text] [Related]
3. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial. Malamiri RA, Ghaempanah M, Khosroshahi N, Nikkhah A, Bavarian B, Ashrafi MR. Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977 [Abstract] [Full Text] [Related]
4. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage. Mink S, Muroi C, Seule M, Bjeljac M, Keller E. Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756 [Abstract] [Full Text] [Related]
5. Intravenous sodium valproate in mainland China for the treatment of diazepam refractory convulsive status epilepticus. Chen L, Feng P, Wang J, Liu L, Zhou D. J Clin Neurosci; 2009 Apr; 16(4):524-6. PubMed ID: 19243950 [Abstract] [Full Text] [Related]
6. Treatment of pediatric epilepsy: European expert opinion, 2007. Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D. Epileptic Disord; 2007 Dec; 9(4):353-412. PubMed ID: 18077226 [Abstract] [Full Text] [Related]
9. Therapeutic drug monitoring of antiepileptic drugs. Shakya G, Malla S, Shakya KN, Shrestha R. JNMA J Nepal Med Assoc; 2008 Dec; 47(171):94-7. PubMed ID: 19079370 [Abstract] [Full Text] [Related]
10. Pharmacokinetics and clinical application of intravenous valproate in Thai epileptic children. Visudtibhan A, Bhudhisawadi K, Vaewpanich J, Chulavatnatol S, Kaojareon S. Brain Dev; 2011 Mar; 33(3):189-94. PubMed ID: 20444563 [Abstract] [Full Text] [Related]
11. [Characteristics of drugs used in the treatment of acute convulsions and convulsive status]. Herranz JL, Argumosa A. Rev Neurol; 2011 Mar; 31(8):757-62. PubMed ID: 11082886 [Abstract] [Full Text] [Related]
12. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children. Panomvana Na Ayudhya D, Suwanmanee J, Visudtibhan A. Am J Ther; 2006 Mar; 13(3):211-7. PubMed ID: 16772762 [Abstract] [Full Text] [Related]
13. Valproate protein binding following rapid intravenous administration of high doses of valproic acid in patients with epilepsy. Dutta S, Faught E, Limdi NA. J Clin Pharm Ther; 2007 Aug; 32(4):365-71. PubMed ID: 17635338 [Abstract] [Full Text] [Related]
15. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs. Ji-qun C, Ishihara K, Nagayama T, Serikawa T, Sasa M. Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430 [Abstract] [Full Text] [Related]
16. Effects of divalproex sodium on hemoglobin level. Taher AT, Musallam KM, Nasreddine W, Perrine SP, El-Hajj TI, Beydoun A. Blood Cells Mol Dis; 2009 Sep; 43(1):49-52. PubMed ID: 19254854 [Abstract] [Full Text] [Related]